E-Cigarettes May Increase Risk of Heart Problems: Study

While many people turn to e-cigarettes, thinking they are a healthier and safer alternative to smoking traditional tobacco cigarettes, research continues to highlight risks associated with the popular devices, with a new study suggesting that vaping may increase the risk of heart disease. 

In findings published in the medical journal JAMA Cardiology on February 1, researchers from the University of California, Los Angeles (UCLA) indicate that e-cigarettes increase a person’s level of free radicals, and thus their risk of heart disease.

Researchers evaluated 42 healthy e-cigarette users ages 21 to 45, between 2015 and 2016. They compared those participants to 19 non-tobacco cigarette and non-vaping control subjects.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Participants had no known health problems, did not use prescription medications or tobacco cigarettes. Control participants had the same parameters, but also did not use e-cigarettes. They conducted blood tests, heart rate variability tests, and measured heart behavior.

The study linked two early indicators of heart risk with e-cigarette use. Among vape users, heart rate variability was shifted toward increased sympathetic predominance. Researchers indicated that the increased risk of cardiac sympathetic activity, as seen in e-cigarette users, also leads to increased heart rate and higher blood pressure. This puts them at risk for other heart relate problems over time.

These same abnormalities are seen in tobacco smokers. E-cigarette users also had higher levels of oxidative stress.

The researchers also found high levels of free radical molecules produced through breathing, which began to reach potentially harmful levels that are associated with cardiac risk.

Other research published in recent years has highlighted the potential health side effects of e-cigarettes, with another recent study concluding that vaping increases risk of oral disease, including oral cancer. The study indicated vaping reduced oral cells by 85%, mostly caused by decreased levels of antioxidants.

A study published last year indicated e-cigarettes emitted high levels of toxic chemicals not previously detected in e-cigarette vapors, causing unforeseen side effects.

This is the first study to look at cardiac risk factors in connection with habitual e-cigarette users.

Dr. Holly Middlekauff, lead author of the study and professor with the division of cardiology at UCLA, said the results were surprising considering e-cigarettes are believed to be less harmful than tobacco cigarettes. Yet, the results are concerning since some research has indicated that e-cigarettes are just as addictive as tobacco cigarettes.

The study shows an association between heart disease and e-cigarette use, but not a cause and effect relationship, the researchers noted. It is unclear exactly why e-cigarettes increase a person’s risk of heart problems, but researchers speculate the answer may be the inhaled nicotine.

Nicotine is the most biologically active component in e-cigarette aerosol and is an airway irritant. Nicotine also increases the adrenaline levels in the body which can activate other harmful reactions.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL
Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL (Posted 3 days ago)

Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit
Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit (Posted 4 days ago)

California woman indicates she was unaware there was a link between her meningioma and Depo-Provera injections until a study was published in March 2024, resulting in widespread publicity about the brain tumor risks.